Literature DB >> 31971860

John Mendelsohn's journey in cancer biology and therapy.

Rakesh Kumar1,2,3.   

Abstract

Entities:  

Keywords:  Growth factor; cetuximab; legacy; targeted therapy; trastuzumab

Mesh：

Substances：

Year:  2020        PMID： 31971860      PMCID： PMC7515450          DOI： 10.1080/15384047.2020.1712829

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN： 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  17 in total

1.  Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies.

Authors:  H Masui; T Kawamoto; J D Sato; B Wolf; G Sato; J Mendelsohn
Journal:  Cancer Res       Date:  1984-03       Impact factor: 12.701

2.  Ligand-induced activation of A431 cell epidermal growth factor receptors occurs primarily by an autocrine pathway that acts upon receptors on the surface rather than intracellularly.

Authors:  M J Van de Vijver; R Kumar; J Mendelsohn
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

3.  Regulation of phosphorylation of the c-erbB-2/HER2 gene product by a monoclonal antibody and serum growth factor(s) in human mammary carcinoma cells.

Authors:  R Kumar; H M Shepard; J Mendelsohn
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

Review 4.  A Tribute to John Mendelsohn: A Pioneer in Targeted Cancer Therapy.

Authors:  Rakesh Kumar; Marc Van de Vijver; Giampaolo Tortora; Fortunato Ciardiello; Tzipora Goldkorn; Wilson H Miller; Larry Norton
Journal:  Cancer Res       Date:  2019-06-18       Impact factor: 12.701

5.  Humanization of an anti-p185HER2 antibody for human cancer therapy.

Authors:  P Carter; L Presta; C M Gorman; J B Ridgway; D Henner; W L Wong; A M Rowland; C Kotts; M E Carver; H M Shepard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

6.  Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.

Authors:  T Kawamoto; J D Sato; A Le; J Polikoff; G H Sato; J Mendelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

7.  Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors.

Authors:  J D Sato; T Kawamoto; A D Le; J Mendelsohn; J Polikoff; G H Sato
Journal:  Mol Biol Med       Date:  1983-12

8.  Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.

Authors:  J Baselga; L Norton; H Masui; A Pandiella; K Coplan; W H Miller; J Mendelsohn
Journal:  J Natl Cancer Inst       Date:  1993-08-18       Impact factor: 13.506

9.  Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity.

Authors:  G N Gill; T Kawamoto; C Cochet; A Le; J D Sato; H Masui; C McLeod; J Mendelsohn
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

10.  John Mendelsohn: A visionary scientist, oncologist and leader.

Authors:  Rakesh Kumar; Ferid Murad; Oliver Bogler; Bert W O'Malley; Gabriel N Hortobagyi
Journal:  Genes Cancer       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.